Cargando…
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention
The clinical standard of care for urothelial carcinoma (UC) relies on invasive procedures with suboptimal performance. To enhance UC treatment, we developed a urinary comprehensive genomic profiling (uCGP) test, UroAmplitude, that measures mutations from tumor DNA present in urine. In this study, we...
Autores principales: | Bicocca, Vincent T., Phillips, Kevin G., Fischer, Daniel S., Caruso, Vincent M., Goudarzi, Mahdi, Garcia-Ransom, Monica, Lentz, Peter S., MacBride, Andrew R., Jensen, Brad W., Mazzarella, Brian C., Koppie, Theresa, Korkola, James E., Gray, Joe W., Levin, Trevor G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571552/ https://www.ncbi.nlm.nih.gov/pubmed/36233691 http://dx.doi.org/10.3390/jcm11195827 |
Ejemplares similares
-
Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
por: Salari, Keyan, et al.
Publicado: (2023) -
Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease
por: Butler, Timothy M., et al.
Publicado: (2015) -
Cases from Dr Scott Orr's Clinique
por: MacBride, Charles
Publicado: (1873) -
Atmospheres, landscapes and nature: Off-road runners’ experiences of well-being
por: MacBride-Stewart, Sara
Publicado: (2019) -
Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot Microarrays
por: Rantala, Juha K., et al.
Publicado: (2013)